[TEVA] YoY Quarter Result on 31-Dec-2022 [#Q4]

Stock
[TEVA] Teva Pharmaceutical Industries Limited
Announcement Date
10-Feb-2023
Financial Year
2022
Quarter
31-Dec-2022 [#Q4]
Profit Trend
QoQ- -2,280.36%
YoY- -667.92%
Quarter Report
TEVA's Result
TEVA's Financial Summary
View:
Show?
Quarter Result
31/12/24 31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 CAGR
Revenue 4,229,000 4,457,000 3,884,000 4,100,000 4,452,000 4,468,000 4,559,000 -1.24%
PBT -247,000 473,000 -1,100,000 -175,000 137,000 -38,000 -3,387,000 -35.33%
Tax -30,000 41,000 154,000 -24,000 -21,000 -119,000 -139,000 -22.53%
NP -217,000 429,000 -1,221,000 -159,000 150,000 109,000 -2,886,000 -35.00%
Tax Rate - -8.67% - - 15.33% - - -
Total Cost 4,446,000 4,028,000 5,105,000 4,259,000 4,302,000 4,359,000 7,445,000 -8.22%
Ratio Analysis
31/12/24 31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 CAGR
NP Margin -5.13 9.63 -31.44 -3.88 3.37 2.44 -63.30 -34.19%
Per Share
31/12/24 31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 CAGR
EPS -0.19 0.41 -1.10 -0.14 0.14 0.10 -2.80 -36.10%
EPS Diluted -0.19 0.41 -1.10 -0.14 0.14 0.10 -2.80 -36.10%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.